One person. One project at a time.

From loss models to evidence synthesis

Over ten years' experience in commercial insurance pricing at a top insurer, alongside a degree in data science — building loss-model frameworks deployed globally across many lines of business, including cyber and life sciences liability. That work is an ongoing education in how decision-makers actually use evidence under deadline pressure: what they read, what they discount, and what makes a number worth acting on.

Evidensity grew out of that, and out of a stubborn appetite for learning new domains. The pipeline behind every brief reflects the actuary's instinct: structured extraction, explicit uncertainty, audit trails, and a refusal to let any quantity travel without its source.

Operating principles

• † One engagement at a time. No team, no handoffs. The person who scopes your brief is the person who delivers it.
• † Free scoping, returned in 24 hours. Send the question. Get back the evidence landscape — how many papers exist, the major themes, what a full analysis would reveal. No commitment.
• † Every claim, cited. Every quantity, finding, and assertion in every report is traced back to a verified source quote. Hover any citation and read the paper's own words.
• † Self-contained, archive-stable deliverables. Reports are single HTML files with embedded citations and tooltips. Readable by your team without dependencies, indexable in your own systems, and unchanged five years from now.
• † Methodology, not summarisation. PRISMA-aligned screening, structured extraction, credibility scoring, and where the data permits, real quantitative meta-analysis — REML random-effects pooling with forest plots and prediction intervals.

Where the actuarial work meets clinical evidence

Pricing cyber and life sciences liability cover means sustained exposure to how clinical and safety evidence is weighted under regulatory and financial scrutiny — what an underwriter accepts, what a regulator wants, where signal stops being signal. That perspective travels into the medical affairs, HEOR, and payer-facing work Evidensity is built for today.

A vertical landing for pharma evidence work — with two worked examples, GLP-1 receptor agonists in cardiovascular outcomes and direct oral anticoagulants in atrial fibrillation, each reproducing a published meta-analysis — is here: Pharmaceutical SLR — live demo.

Start with a question

Free scoping assessment, returned within 24 hours. No commitment.

Commission a brief

or email directly: evidensity.research@gmail.com